|Grant Affiliation:||Third party request|
|Strategy:||Protein & peptide vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2014-02-19|
|Study Made Public:||2014-10-06|
CAVD 442 is a preclinical guinea pig study comparing 3 epitope-rich structures (ERS) of the HIV-1 envelope (gp41fi, bV3, and V1V2) to the entire envelope.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.